Qiu, H. (2020). Safety and efficacy of tislelizumab plus chemotherapy for first‐line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma. Thorac Cancer.
Citación estilo ChicagoQiu, Hai‐Bo. "Safety and Efficacy of Tislelizumab Plus Chemotherapy for First‐line Treatment of Advanced Esophageal Squamous Cell Carcinoma and Gastric/gastroesophageal Junction Adenocarcinoma." Thorac Cancer 2020.
Cita MLAQiu, Hai‐Bo. "Safety and Efficacy of Tislelizumab Plus Chemotherapy for First‐line Treatment of Advanced Esophageal Squamous Cell Carcinoma and Gastric/gastroesophageal Junction Adenocarcinoma." Thorac Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.